Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
about
Behavioral Symptoms after Breast Cancer Treatment: A Biobehavioral ApproachNeuroimmune mechanisms of depressionImmune and Neuroendocrine Mechanisms of Stress Vulnerability and ResilienceThe Microbiota, Immunoregulation, and Mental Health: Implications for Public Health.Effects of Group Drumming Interventions on Anxiety, Depression, Social Resilience and Inflammatory Immune Response among Mental Health Service Users.Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.Biomarkers for depression: recent insights, current challenges and future prospects.Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders.A multispecies approach for understanding neuroimmune mechanisms of stress.Immunological aspects of the treatment of depression and schizophrenia.Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine ReceptorThe microbiome, immunity, and schizophrenia and bipolar disorderInflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study.Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.Investigational drugs in recent clinical trials for treatment-resistant depression.Cytokine variations and mood disorders: influence of social stressors and social support.Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes.Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disordersA bidirectional relationship between depression and the autoimmune disorders - New perspectives from the National Child Development StudyPathogenesis of depression: Insights from human and rodent studies.Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?Depressive-like behavior, its sensitization, social buffering, and altered cytokine responses in rhesus macaques moved from outdoor social groups to indoor housing.Immune signatures and disorder-specific patterns in a cross-disorder gene expression analysis.Inflammation in Depression and the Potential for Anti-Inflammatory TreatmentInflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial.Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression.Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression.EGb761 attenuates depressive-like behaviours induced by long-term light deprivation in C57BL/6J mice through inhibition of NF-κB-IL-6 signalling pathway.Are medical comorbid conditions of bipolar disorder due to immune dysfunction?Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?Five potential therapeutic agents as antidepressants: a brief review and future directions.Backing into the future: pharmacological approaches to the management of resistant depressionAspirin and incident depressive symptoms: A longitudinal cohort study over 8 years.The renin-angiotensin system: a possible new target for depression.
P2860
Q26801476-C4802376-60FA-4884-B7BA-0EF080407174Q28084450-C9943458-5170-4926-9532-B80400A68CF5Q28396103-E8AE06DA-7634-49A9-B68A-DFD5C21FB3FCQ30248903-9061DCDB-06CC-4812-930D-E57B37DB42DEQ30385640-6FEC475A-5E66-4A25-948E-EB5E0E944D76Q31141746-5F1CD053-0ABD-4715-B5D4-EF57561424F8Q33635571-22A77DDF-EB7C-46F2-BEB0-543854BF0467Q33704099-724A97C1-71C1-443E-850B-3FA4C00AAE7AQ33721019-A3B6D3E9-6673-4D1D-98F8-A9CB2E43CD39Q33721025-7A665306-8DFB-4C46-894F-97D6B4F364D1Q33721031-BC104828-C2FB-45BC-89FB-A30F1F1CDEEBQ33740560-8E7C6517-C0A3-4877-BEF7-0368D3FBCB92Q33887751-56C46362-4EC1-4A0D-8BBE-BFDE6F84E84BQ34468355-A4C0A50E-B7BA-49A3-AB6F-B055A7AF0A52Q34480323-7287B229-537B-4A47-A21A-9D26A92723E8Q34549390-876EC4B7-A5AD-4509-870C-31B28F64439EQ34708116-77675E22-BCAC-4943-B5BE-18796AAF77B5Q36023793-846234EC-3918-4848-93F6-0AF6A0253009Q36052673-096481B3-1FA4-4CDA-94C8-805799C57C74Q36169850-BBEB409B-8DF0-4A77-882C-6B5477C050EFQ36298324-5F888FC0-137E-4A89-B1EF-77C44B9BC9A3Q36332597-96085F1F-A03D-4FFA-AEE8-019841CD1B9AQ36770623-04923D70-BC7E-4A77-9E6A-2894AC3DB168Q36789308-64232CA3-CF41-4ECF-9D6E-DB2FE3A698D7Q37184276-171F101B-2386-4F35-B6DA-BE3D73764D3AQ37223293-F0B6A3F0-55BA-4402-8799-292D24979855Q37310528-FBC309BB-DAEE-47F5-B209-406F1F7199F7Q37310533-E17C4863-3349-4FDF-9B1D-B3FD838F00DDQ37530855-4542E460-C98B-4891-95D1-4024529828C4Q37532906-86ADC86C-16B6-4BB5-A77B-C05D7FCF677DQ37605157-D11BFF3B-E93C-478E-802C-89D4067E764BQ37739793-D5761492-26D0-41A7-B09E-0464F43913E2Q38378743-E0B09B77-E5C7-4A5F-B432-80E01D4180C8Q38454097-5337712A-692B-4CB5-ACEC-59925DEB9942Q38543238-7899830A-998C-406F-8900-C56AD920489EQ38565570-B5603EFF-B672-431E-B849-B660A6AC8288Q38574831-3653CCB6-A188-44A4-BA44-14102DD76658Q38637621-6E6E2620-C019-4C34-99F7-63923350A26DQ38637748-EC3FDAB2-EF46-4FA7-8684-17E7D802FD53Q38651269-0BC1E493-C1E9-4DED-B6AA-0B597AED7EE4
P2860
Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Effect of anti-inflammatory tr ...... of randomized clinical trials.
@ast
Effect of anti-inflammatory tr ...... of randomized clinical trials.
@en
Effect of anti-inflammatory tr ...... of randomized clinical trials.
@nl
type
label
Effect of anti-inflammatory tr ...... of randomized clinical trials.
@ast
Effect of anti-inflammatory tr ...... of randomized clinical trials.
@en
Effect of anti-inflammatory tr ...... of randomized clinical trials.
@nl
prefLabel
Effect of anti-inflammatory tr ...... of randomized clinical trials.
@ast
Effect of anti-inflammatory tr ...... of randomized clinical trials.
@en
Effect of anti-inflammatory tr ...... of randomized clinical trials.
@nl
P2093
P50
P1433
P1476
Effect of anti-inflammatory tr ...... of randomized clinical trials.
@en
P2093
Jesper Krogh
Michael E Farkouh
Rupa L Iyengar
P304
P356
10.1001/JAMAPSYCHIATRY.2014.1611
P407
P577
2014-12-01T00:00:00Z